Search

Your search keyword '"Quintanar-Verdúguez T"' showing total 9 results
Start Over Author "Quintanar-Verdúguez T"
9 results on '"Quintanar-Verdúguez T"'

4. 1856P Prediction of clinically significant bleeding in anticoagulated patients for cancer-associated venous thromboembolism: Validation of B-CAT score in a cohort from the TESEO study

Author

López Robles, J., Sanchez Canovas, M., Iglesias Pérez, C., Ortega Morán, L., Sánchez Togneri, L., Rubio Perez, J., Fernandez Perez, I., Garcia De Herreros, M., Garcia Escobar, I., Porta-Balanya, R., Brozos Vazquez, E.M., Carmona Campos, M., Martinez de Castro, E., Olivares Barreiro, H., Quintanar Verduguez, T., Garcia-Adrian, S., Covela, M., Guirao García, M.E., Jimenez Fonseca, P., and Munoz Martin, A.J.

Published
2024
Full Text
View/download PDF

7. 344MO Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma

Author

Vieito Villar, M., Luque Caro, R., Martin Soberon, M.C., Herrero Ibañez, A., Girones Sarrio, R., Luque Caro, N., Alonso Garcia, M., Quintanar Verduguez, T., del Barco Berrón, S., Moya Horno, I., Tuñón Cabeza, M.T., Gallego, O., de las Peñas, R., Vaz Salgado, M.Á., Ceballos Lenza, I., Cunquero-Tomás, A.J., Peralta Muñoz, S., Gutierrez Toribio, M., and Diaz Santos, J.

Published
2021
Full Text
View/download PDF

8. Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.

Author

Sánchez Cánovas M, Moya Hernández MÁ, Adoamnei E, Cacho Lavin D, Fernández Garay D, Quintanar Verdúguez T, Rogado Revuelta J, García Verdejo FJ, García Adrián S, Ferrer Pérez AI, Guirao García ME, López Robles J, Mendiola J, and Muñoz Martín AJ

Subjects
Humans, Male, Retrospective Studies, Female, Middle Aged, Aged, Spain epidemiology, Thrombosis chemically induced, Thrombosis etiology, Incidence, Adult, Aged, 80 and over, Follow-Up Studies, Medical Oncology, Societies, Medical, Head and Neck Neoplasms drug therapy, Immune Checkpoint Inhibitors adverse effects, Immune Checkpoint Inhibitors therapeutic use
Abstract

Purpose: Both venous and arterial thrombotic events (VTE/AT) can be associated with Immune Checkpoint Inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice., Methods: /Patients. This retrospective, multicenter study was promoted by the Thrombosis and Cancer Section of the Spanish Society of Medical Oncology (SEOM). Individuals with head and neck cancer who initiated ICI between 01/01/2015 and 31/12/2021 were recruited. Minimum follow-up was 6 months (except in cases of demise). The primary objective was to calculate the incidence of ICI-associated VTE/AT, with secondary objectives including the analysis of their impact on survival and the identification of variables predictive of VTE/AT., Results: A total of 143 patients with head and neck cancer were enrolled. The incidence of VTE/AT during follow-up (median 8.6 months) was 2.8%. Survival analysis showed no significant differences (p = 0.644) between the group that developed VTE/AT (median 7.13 months, 95% CI 0-22.9) and the group that did not (median 9.86 months, 95% CI 6.3-13.4). The presence of liver metastases was predictive of VTE/AT (p < 0.05)., Conclusions: Thromboembolic disease associated with immunotherapy in patients with head and neck neoplasia does not significantly impact survival. The presence of liver metastases can predict these events., (© 2024. The Author(s).)

Published
2025
Full Text
View/download PDF

9. Mediastinal extravasation of doxorubicin.

Author

Quintanar Verdúguez T, Blanco Jarava A, Martínez-Barbeito MB, Pangua Méndez C, López Gómez L, Andrade Santiago J, and Chacón López-Muñiz I

Subjects
Catheters, Indwelling adverse effects, Female, Humans, Infusions, Intravenous, Middle Aged, Pleural Effusion etiology, Antineoplastic Agents administration & dosage, Breast Neoplasms drug therapy, Catheterization, Central Venous adverse effects, Doxorubicin administration & dosage, Extravasation of Diagnostic and Therapeutic Materials complications, Mediastinum pathology
Abstract

A 48-year-old woman with a diagnosis of breast carcinoma was treated with adjuvant chemotherapy through a central venous catheter with subcutaneous reservoir (Port-A-Cath). While doxorubicin was administered, the patient presented thoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum. The patient recovered without sequelae with conservative therapy. Cytostatic extravasation via central catheter is an uncommon complication in clinical practice. In this paper we present the first doxorubicin extravasation through a central catheter in adults and review the only ten cases found in the literature.

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results